Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1
Microsomal prostaglandin E(2) synthase (mPGES-1) represents a potential target for novel analgesic and anti-inflammatory agents. High-throughput screening identified several leads of mPGES-1 inhibitors which were further optimized for potency and selectivity. A series of inhibitors bearing a biaryl...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2010-12, Vol.20 (23), p.6978-6982 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6982 |
---|---|
container_issue | 23 |
container_start_page | 6978 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 20 |
creator | WU, Tom Y. H JUTEAU, Hélène BRIDEAU, Christine DUCHARME, Yves FRIESEN, Richard W GUIRAL, Sébastien DUFRESNE, Lynn POIRIER, Hugo SALEM, Myriam RIENDEAU, Denis MANCINI, Joseph |
description | Microsomal prostaglandin E(2) synthase (mPGES-1) represents a potential target for novel analgesic and anti-inflammatory agents. High-throughput screening identified several leads of mPGES-1 inhibitors which were further optimized for potency and selectivity. A series of inhibitors bearing a biaryl imidazole scaffold exhibits excellent inhibition of PGE(2) production in enzymatic and cell-based assays. The synthesis of these molecules and their activities will be discussed. |
doi_str_mv | 10.1016/j.bmcl.2010.09.129 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_763174181</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>763174181</sourcerecordid><originalsourceid>FETCH-LOGICAL-c272t-9e0eacc7bd5dd55bcbd2fb31c4408b2ca69704dcdfdf11ced9032334c0cd0ca13</originalsourceid><addsrcrecordid>eNpFkMtOwzAQRS0EoqXwAyxQNohVwviRh5dQFYpUiQ1I7Cy_Ql05SYnTRfl6HLXAaqzxmdGdg9A1hgwDLu43mWq0zwjEBvAME36CppgVLKUM8lM0BV5AWnH2MUEXIWwAMAPGztGExJ-8JHSKlo9O9nvvGmfkd-dtSGRIXLt2yg1dH5KuThqn-y50jfTJNj4G-ella1ybLEgS9u2wlsGm-BKd1dIHe3WsM_T-tHibL9PV6_PL_GGValKSIeUWrNS6VCY3Js-VVobUimLNGFSKaFnwEpjRpjY1xtoaDpRQyjRoA1piOkN3h70xy9fOhkE0LmjrYybb7YIoC4pLhquRJAdyjB96W4tt75p4rcAgRoFiI0aBYhQogIsoMA7dHNfvVGPN38ivsQjcHgEZtPR1L1vtwj9HGalYwekPp2d7uw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>763174181</pqid></control><display><type>article</type><title>Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>WU, Tom Y. H ; JUTEAU, Hélène ; BRIDEAU, Christine ; DUCHARME, Yves ; FRIESEN, Richard W ; GUIRAL, Sébastien ; DUFRESNE, Lynn ; POIRIER, Hugo ; SALEM, Myriam ; RIENDEAU, Denis ; MANCINI, Joseph</creator><creatorcontrib>WU, Tom Y. H ; JUTEAU, Hélène ; BRIDEAU, Christine ; DUCHARME, Yves ; FRIESEN, Richard W ; GUIRAL, Sébastien ; DUFRESNE, Lynn ; POIRIER, Hugo ; SALEM, Myriam ; RIENDEAU, Denis ; MANCINI, Joseph</creatorcontrib><description>Microsomal prostaglandin E(2) synthase (mPGES-1) represents a potential target for novel analgesic and anti-inflammatory agents. High-throughput screening identified several leads of mPGES-1 inhibitors which were further optimized for potency and selectivity. A series of inhibitors bearing a biaryl imidazole scaffold exhibits excellent inhibition of PGE(2) production in enzymatic and cell-based assays. The synthesis of these molecules and their activities will be discussed.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2010.09.129</identifier><identifier>PMID: 20965723</identifier><language>eng</language><publisher>Amsterdam: Elsevier</publisher><subject>Animals ; Anti-Inflammatory Agents - chemistry ; Anti-Inflammatory Agents - pharmacology ; Biological and medical sciences ; Bones, joints and connective tissue. Antiinflammatory agents ; Cell Line ; Dinoprostone - antagonists & inhibitors ; Dinoprostone - biosynthesis ; High-Throughput Screening Assays ; Imidazoles - chemistry ; Imidazoles - pharmacology ; Intramolecular Oxidoreductases - antagonists & inhibitors ; Medical sciences ; Mice ; Microsomes - enzymology ; Pharmacology. Drug treatments ; Prostaglandin-E Synthases</subject><ispartof>Bioorganic & medicinal chemistry letters, 2010-12, Vol.20 (23), p.6978-6982</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c272t-9e0eacc7bd5dd55bcbd2fb31c4408b2ca69704dcdfdf11ced9032334c0cd0ca13</citedby><cites>FETCH-LOGICAL-c272t-9e0eacc7bd5dd55bcbd2fb31c4408b2ca69704dcdfdf11ced9032334c0cd0ca13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23428469$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20965723$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WU, Tom Y. H</creatorcontrib><creatorcontrib>JUTEAU, Hélène</creatorcontrib><creatorcontrib>BRIDEAU, Christine</creatorcontrib><creatorcontrib>DUCHARME, Yves</creatorcontrib><creatorcontrib>FRIESEN, Richard W</creatorcontrib><creatorcontrib>GUIRAL, Sébastien</creatorcontrib><creatorcontrib>DUFRESNE, Lynn</creatorcontrib><creatorcontrib>POIRIER, Hugo</creatorcontrib><creatorcontrib>SALEM, Myriam</creatorcontrib><creatorcontrib>RIENDEAU, Denis</creatorcontrib><creatorcontrib>MANCINI, Joseph</creatorcontrib><title>Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Microsomal prostaglandin E(2) synthase (mPGES-1) represents a potential target for novel analgesic and anti-inflammatory agents. High-throughput screening identified several leads of mPGES-1 inhibitors which were further optimized for potency and selectivity. A series of inhibitors bearing a biaryl imidazole scaffold exhibits excellent inhibition of PGE(2) production in enzymatic and cell-based assays. The synthesis of these molecules and their activities will be discussed.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents - chemistry</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Cell Line</subject><subject>Dinoprostone - antagonists & inhibitors</subject><subject>Dinoprostone - biosynthesis</subject><subject>High-Throughput Screening Assays</subject><subject>Imidazoles - chemistry</subject><subject>Imidazoles - pharmacology</subject><subject>Intramolecular Oxidoreductases - antagonists & inhibitors</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Microsomes - enzymology</subject><subject>Pharmacology. Drug treatments</subject><subject>Prostaglandin-E Synthases</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMtOwzAQRS0EoqXwAyxQNohVwviRh5dQFYpUiQ1I7Cy_Ql05SYnTRfl6HLXAaqzxmdGdg9A1hgwDLu43mWq0zwjEBvAME36CppgVLKUM8lM0BV5AWnH2MUEXIWwAMAPGztGExJ-8JHSKlo9O9nvvGmfkd-dtSGRIXLt2yg1dH5KuThqn-y50jfTJNj4G-ella1ybLEgS9u2wlsGm-BKd1dIHe3WsM_T-tHibL9PV6_PL_GGValKSIeUWrNS6VCY3Js-VVobUimLNGFSKaFnwEpjRpjY1xtoaDpRQyjRoA1piOkN3h70xy9fOhkE0LmjrYybb7YIoC4pLhquRJAdyjB96W4tt75p4rcAgRoFiI0aBYhQogIsoMA7dHNfvVGPN38ivsQjcHgEZtPR1L1vtwj9HGalYwekPp2d7uw</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>WU, Tom Y. H</creator><creator>JUTEAU, Hélène</creator><creator>BRIDEAU, Christine</creator><creator>DUCHARME, Yves</creator><creator>FRIESEN, Richard W</creator><creator>GUIRAL, Sébastien</creator><creator>DUFRESNE, Lynn</creator><creator>POIRIER, Hugo</creator><creator>SALEM, Myriam</creator><creator>RIENDEAU, Denis</creator><creator>MANCINI, Joseph</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101201</creationdate><title>Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1</title><author>WU, Tom Y. H ; JUTEAU, Hélène ; BRIDEAU, Christine ; DUCHARME, Yves ; FRIESEN, Richard W ; GUIRAL, Sébastien ; DUFRESNE, Lynn ; POIRIER, Hugo ; SALEM, Myriam ; RIENDEAU, Denis ; MANCINI, Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c272t-9e0eacc7bd5dd55bcbd2fb31c4408b2ca69704dcdfdf11ced9032334c0cd0ca13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents - chemistry</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Cell Line</topic><topic>Dinoprostone - antagonists & inhibitors</topic><topic>Dinoprostone - biosynthesis</topic><topic>High-Throughput Screening Assays</topic><topic>Imidazoles - chemistry</topic><topic>Imidazoles - pharmacology</topic><topic>Intramolecular Oxidoreductases - antagonists & inhibitors</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Microsomes - enzymology</topic><topic>Pharmacology. Drug treatments</topic><topic>Prostaglandin-E Synthases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WU, Tom Y. H</creatorcontrib><creatorcontrib>JUTEAU, Hélène</creatorcontrib><creatorcontrib>BRIDEAU, Christine</creatorcontrib><creatorcontrib>DUCHARME, Yves</creatorcontrib><creatorcontrib>FRIESEN, Richard W</creatorcontrib><creatorcontrib>GUIRAL, Sébastien</creatorcontrib><creatorcontrib>DUFRESNE, Lynn</creatorcontrib><creatorcontrib>POIRIER, Hugo</creatorcontrib><creatorcontrib>SALEM, Myriam</creatorcontrib><creatorcontrib>RIENDEAU, Denis</creatorcontrib><creatorcontrib>MANCINI, Joseph</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WU, Tom Y. H</au><au>JUTEAU, Hélène</au><au>BRIDEAU, Christine</au><au>DUCHARME, Yves</au><au>FRIESEN, Richard W</au><au>GUIRAL, Sébastien</au><au>DUFRESNE, Lynn</au><au>POIRIER, Hugo</au><au>SALEM, Myriam</au><au>RIENDEAU, Denis</au><au>MANCINI, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>20</volume><issue>23</issue><spage>6978</spage><epage>6982</epage><pages>6978-6982</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>Microsomal prostaglandin E(2) synthase (mPGES-1) represents a potential target for novel analgesic and anti-inflammatory agents. High-throughput screening identified several leads of mPGES-1 inhibitors which were further optimized for potency and selectivity. A series of inhibitors bearing a biaryl imidazole scaffold exhibits excellent inhibition of PGE(2) production in enzymatic and cell-based assays. The synthesis of these molecules and their activities will be discussed.</abstract><cop>Amsterdam</cop><pub>Elsevier</pub><pmid>20965723</pmid><doi>10.1016/j.bmcl.2010.09.129</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2010-12, Vol.20 (23), p.6978-6982 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_proquest_miscellaneous_763174181 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Animals Anti-Inflammatory Agents - chemistry Anti-Inflammatory Agents - pharmacology Biological and medical sciences Bones, joints and connective tissue. Antiinflammatory agents Cell Line Dinoprostone - antagonists & inhibitors Dinoprostone - biosynthesis High-Throughput Screening Assays Imidazoles - chemistry Imidazoles - pharmacology Intramolecular Oxidoreductases - antagonists & inhibitors Medical sciences Mice Microsomes - enzymology Pharmacology. Drug treatments Prostaglandin-E Synthases |
title | Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T15%3A33%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biarylimidazoles%20as%20inhibitors%20of%20microsomal%20prostaglandin%20E2%20synthase-1&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=WU,%20Tom%20Y.%20H&rft.date=2010-12-01&rft.volume=20&rft.issue=23&rft.spage=6978&rft.epage=6982&rft.pages=6978-6982&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2010.09.129&rft_dat=%3Cproquest_cross%3E763174181%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=763174181&rft_id=info:pmid/20965723&rfr_iscdi=true |